Ligand · L5G
L5G · 7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline
L5G, 7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline (C22 H17 N5 O2, 383.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- L5G
- Formula
- C22 H17 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
L5G in 2 structures; the first of them:
- 3CD8 · X-ray Structure of c-Met with triazolopyridazine Inhibitor. · L5G A1 · binds ILE1084, GLY1085, VAL1092, ALA1108, LEU1140, LEU1157, PRO1158, TYR1159 and 10 more
- 3CD8 · X-ray structure of C-met with triazolopyridazine inhibitor. · L5G A1 · binds ILE1084, GLY1085, VAL1092, ALA1108, LEU1140, LEU1157, PRO1158, TYR1159 and 10 more
Residues it binds most
ALA 2, ASP 2, LEU 2, MET 2, TYR 2, ARG 2, ASN 2, GLY 2, ILE 2, LYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.